Corporate Ads

NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties

Cadrenal Therapeutics, Inc. (Stock Symbol: CVKD) $CVKD Tecarfarin Anticoagulant Reduces Drug on Drug Interactions Which Pose a Major Issue with Warfarin. Successful Phase III Could Enhance Liquidity and Quickly Attract Large Institutional Investors.

Cybersecurity stocks to watch: $cycu $panw $zs $crwd $chkp $cybr $ftnt $okta $net $ffiv

IQSTEL, Inc. (Stock Symbol: IQSTD) On Track Towards $1 Billion in Revenue by 2027.

$BEAT Clinical Endpoints Successfully Met in Pivotal Study, Plus FDA Clearance for At-Home, High-Fidelity Heart Monitoring System.

$IQSTD Also Signs MOU to Acquire Majority Stake in Fintech Leader GlobeTopper, Plus $1 Million Subsidiary Sale with Stock Dividend to Shareholders. iQSTEL, Inc. (Stock Symbol: IQSTD)

$NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties. NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)

$300 Million Set up in Milestones for $NRXP on Tiered Double-Digit Royalties

$BEAT Forms Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care. HeartBeam, Inc. (Stock Symbol: BEAT)

NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties